SAGE-NCE (SAGE Therapeutics)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameSAGE-NCE (SAGE Therapeutics)
Drug Alias Namenext generation GABA A allosteric modulator (SAGE Therapeutic)
ClassificationSmall molecules
Mechanisms of ActionNeuroprotectantsGamma-aminobutyric acid A receptor modulators
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsStatus Epilepticus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSage Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSage Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsStatus Epilepticus

Other Information

ATC CodeN/A
Related LinksN/A